Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmic Business News
Merck to acquire EyeBio
Merck will acquire EyeBio through a subsidiary in an agreement potentially valued at $3 billion, according to a press release.
Bausch + Lomb receives Canadian approval for enVista Envy IOL
Health Canada approved the enVista Envy full visual range IOL, the first global approval for the lens, according to a press release from Bausch + Lomb.
BLOG: AI and ophthalmology marketing: Pandora’s box or Cassandra’s prophecy?
Ophthalmology practices increasingly face a choice in how their marketing operations are run: Embrace AI-enabled systems and stay competitive, or maintain traditional but proven promotional strategies and possibly be left behind.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves aflibercept biosimilars Yesafili, Opuviz
The FDA approved Yesafili and Opuviz as the first interchangeable biosimilars to Eylea, according to a press release from the FDA.
FDA grants de novo authorization to AI-powered Scanly Home OCT device
The FDA granted de novo marketing authorization to Notal Vision for the patient self-operated AI-powered Scanly Home OCT device, according to a press release.
Physician practice owners need to review key financial data points regularly
A physician practice owner’s week is spent seeing and caring for patients and managing the day-to-day issues of the practice.
VIDEO: Oculis CEO delivers updates on OCS-01 eye drop trials for DME
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Riad Sherif, MD, CEO of Oculis, discusses the company’s two phase 3 clinical trials for the OCS-01 eye drop.
VIDEO: Duravyu for wet AMD to enter phase 3 pivotal trials in second half of 2024
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Jay S. Duker, MD, of EyePoint Pharmaceuticals discusses lead product Duravyu.
Elevate your Game: Strategies for leaders mentoring the next generation
In this episode, Dagny Zhu, MD, Cathleen McCabe, MD, and Susan MacDonald, MD, chat with Jeannette Bankes about leadership in eye care and mentoring the next generation of leaders.
Qlaris raises $24 million for development of IOP-lowering therapy
Qlaris Bio raised $24 million during series B financing for the clinical development of QLS-111, a new IOP-lowering drug candidate for patients with glaucoma, the company announced in a press release.
-
Headline News
FDA OK’s first artificial pancreas for managing type 1 diabetes during pregnancy
May 24, 20241 min read -
Headline News
Suicides account for more than half of youth firearm deaths in 19 states
May 23, 20243 min read -
Headline News
Q&A: Addressing stroke risk factors in younger persons a complex issue
May 24, 20243 min read
-
Headline News
FDA OK’s first artificial pancreas for managing type 1 diabetes during pregnancy
May 24, 20241 min read -
Headline News
Suicides account for more than half of youth firearm deaths in 19 states
May 23, 20243 min read -
Headline News
Q&A: Addressing stroke risk factors in younger persons a complex issue
May 24, 20243 min read